Table 1 Clinical and pathologic features of patients.
From: Claudin7 and moesin in endometrial Adenocarcinoma; a retrospective study of 265 patients
No. of evaluable patients | 265 |
|---|---|
Follow time, year | |
Median | 2.74 |
Age, year | |
Median | 65 |
Range | 29-97 |
Stage | |
I | 174(66) |
II | 36(14) |
III | 36(14) |
IV | 19(7) |
Subtype | |
Endometiriod | 192(73) |
USC+CCC | 54(20) |
Carcinosarcoma | 19(7) |
Grade(FIGO) | |
1 | 113(43) |
2 | 49(18) |
3 | 103(39) |
Grade(Nuclear) | |
1 | 88(33) |
2 | 70(26) |
3 | 107(40) |
Tumor size, cm | |
Median(Range) | 4.58(0-33) |
< = 2 | 53(20) |
> 2 | 212(80) |
Depth of myometrial invasion | |
Median(Range) | 38.52(0-100) |
< = 50 | 170(64) |
> 50 | 95(36) |
Lympho-vascular involvement | |
no | 192(72) |
yes | 73(28) |
Lymph Node Status | Â |
yes | 41(15) |
no | 119(45) |
Not examined | 105(40) |
Recurrence | Â |
no | 209(79) |
yes | 42(16) |
persistent | 10(4) |
progression | 4(1) |
Status | Â |
ANED | 202(76) |
AWED | 28(11) |
DOD | 22(8) |
DNED | 6(2) |
DWED | 4(2) |
others | 3(1) |
MSN | Â |
negative | 143(54) |
positive | 122(46) |
Claudin7 | Â |
negative | 127(48) |
positive | 138(52) |